Clinical Scorecard: The Relationship Between Obesity and Reproductive Health
At a Glance
Category
Detail
Condition
Obesity-related reproductive dysfunction including male obesity-related secondary hypogonadism (MOSH) and female obesity-related secondary hypogonadism (FOSH), and polycystic ovary syndrome (PCOS)
Obese males and females, including metabolically healthy obese women
Care Setting
Endocrinology, reproductive medicine, fertility clinics, primary care managing obesity
Key Highlights
Obesity causes secondary hypogonadism in males (MOSH) and is a primary risk factor for PCOS and ovulatory dysfunction in females (FOSH).
Reproductive function depends on metabolic fuel availability and signaling molecules such as leptin, insulin, and ghrelin that regulate the HPG axis.
GLP-1 receptor agonists (GLP-1 RAs) are emerging as promising therapies offering reproductive benefits beyond weight loss.
Guideline-Based Recommendations
Diagnosis
Assess reproductive dysfunction in obese patients considering MOSH in males and PCOS or FOSH in females.
Evaluate metabolic and endocrine markers including leptin, insulin resistance, and gonadotropin levels.
Management
Prioritize weight loss through lifestyle interventions, pharmacotherapy, or surgery to preserve fertility.
Consider GLP-1 receptor agonists as adjunct therapy to improve reproductive outcomes.
Address systemic inflammation and insulin resistance as part of comprehensive care.
Monitoring & Follow-up
Regularly monitor reproductive hormone levels and ovulatory function in obese patients.
Track metabolic parameters including glucose homeostasis and inflammatory markers.
Evaluate treatment response to weight loss interventions and GLP-1 RA therapy.
Risks
Persistent obesity increases risk of infertility even in metabolically healthy obese women.
Untreated MOSH and FOSH can lead to long-term reproductive dysfunction and associated comorbidities.
Patient & Prescribing Data
Obese males with MOSH and obese females with PCOS or FOSH
GLP-1 receptor agonists may improve reproductive function beyond weight loss, potentially enhancing fertility when combined with lifestyle or surgical interventions.
Clinical Best Practices
Integrate metabolic and reproductive assessments in obese patients presenting with infertility.
Use a multidisciplinary approach involving endocrinologists, reproductive specialists, and nutritionists.
Employ GLP-1 RAs judiciously as part of a comprehensive fertility preservation strategy.
Educate patients on the critical role of metabolic health in reproductive function.
